"Hørsholm, Denmark (December 11, 2021) — Allarity Therapeutics A/S (“Allarity A/S” or the “Company”) today announced that in excess of 94 % of the Company’s shareholders have accepted the Share Swap Offer, announced on November 24 and expired on December 9, pending final reconciliation. Considering the very high acceptance rate, the Board of Directors has as of today resolved to complete the Share Swap Offer."
"Hørsholm, Denmark (December 13, 2021) — Allarity Therapeutics A/S (“Allarity A/S” or the “Company”) today announced that Nasdaq First North Growth Market Sweden (“Nasdaq First North”) has accepted the Company’s application to delist the shares of Allarity A/S. Allarity A/S submitted the application immediately after publishing the Company’s press release of December 11, 2021, announcing the intention to delist.
Nasdaq First North has published its decision (668/21) on December 13, 2021, announcing that the last day of trading for the Company’s shares on Nasdaq First North will be December 20, 2021.
The delisting process of Allarity Therapeutics A/S does not influence the first day of trading of the shares of Allarity Therapeutics, Inc. on the U.S. Nasdaq stock market scheduled to be on December 21, 2021."
